4//SEC Filing
Mehta Vimal 4
Accession 0001104659-25-074369
CIK 0001720893other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:00 PM ET
Size
5.8 KB
Accession
0001104659-25-074369
Insider Transaction Report
Form 4
Mehta Vimal
DirectorCEO and President
Transactions
- Award
Restricted Stock Units
2025-08-01+18,000→ 18,000 total→ Common Stock (18,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On August 1, 2025 (the "Grant Date"), the Reporting Person was granted 18,000 RSUs, vesting as to 100% on or within thirty (30) days of 9 months from the Grant Date, subject to the Reporting Person's continued employment with the Issuer or a subsidiary of the Issuer on such date.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001733369
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:00 PM ET
- Size
- 5.8 KB